Dentsply Sirona Inc. (XRAY)
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
- Symbol
- XRAY
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Market cap
- $1.98B
- 52 week range
- 9.36 - 14.76
Valuation
- Share price
- $9.78 (close of 2026-09-23)
- P/E (TTM)
- -3.62x
- Price to book
- 1.47x
- Price to free cash flow
- 13.86x
- Enterprise value
- $4.06B
- Book value per share
- $6.78
Price performance
| Period | Change |
|---|
| 1 day | +3.60% |
| 5 days | -0.51% |
| 1 month | -10.44% |
| 3 months | -4.12% |
| 6 months | -15.25% |
| Year to date | -14.44% |
| 1 year | -24.54% |
| 3 years | -71.13% |
| 5 years | -83.59% |
| 10 years | -83.52% |
| All time | +1359.70% |
Profitability and growth
- Return on equity
- -44.63%
- Return on invested capital
- -12.12%
- Return on assets
- -11.01%
- Return on capital employed
- -10.33%
- Gross margin
- 50.00%
- Net margin
- -16.25%
- EBITDA margin
- -1.90%
- Revenue growth
- -2.98%
- Net income growth
- 34.29%
- Free cash flow growth
- -62.99%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 7.21%
- Current ratio
- 1.63x
- Net debt to EBITDA
- 22.29x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $3.68B
- Cost of revenue
- $1.84B
- Gross profit
- $1.84B
- EBITDA
- $-70.00M
- Net income
- $-598.00M
- Earnings per share
- $-3.00
- Research and development
- $150.00M
- Shares outstanding
- 199.40M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $3.68B | $1.84B | $-598.00M | $-3.00 |
| 2024-12-31 | $3.79B | $1.96B | $-910.00M | $-4.48 |
| 2023-12-31 | $3.96B | $2.09B | $-132.00M | $-0.62 |
| 2022-12-31 | $3.92B | $2.13B | $-950.00M | $-4.41 |
| 2021-12-31 | $4.23B | $2.35B | $411.00M | $1.88 |
| 2020-12-31 | $3.34B | $1.66B | $-73.00M | $-0.33 |
| 2019-12-31 | $4.02B | $2.16B | $256.00M | $1.15 |
| 2018-12-31 | $3.99B | $2.07B | $-1.01B | $-4.51 |
| 2017-12-31 | $3.99B | $2.19B | $-1.55B | $-6.76 |
| 2016-12-31 | - | - | $429.90M | $1.97 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | 50.00% | -16.25% | -44.63% | -12.12% |
| 2024-12-31 | 51.62% | -23.99% | -46.83% | -21.63% |
| 2023-12-31 | 52.61% | -3.33% | -4.01% | -0.81% |
| 2022-12-31 | 54.23% | -24.22% | -24.92% | -14.87% |
| 2021-12-31 | 55.47% | 9.71% | 8.22% | 6.82% |
| 2020-12-31 | 49.60% | -2.19% | -1.48% | -0.04% |
| 2019-12-31 | 53.80% | 6.36% | 5.07% | 4.34% |
| 2018-12-31 | 51.88% | -25.36% | -19.89% | -14.90% |
| 2017-12-31 | 54.80% | -38.81% | -23.39% | -18.98% |
| 2016-12-31 | - | - | 5.29% | 4.80% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $326.00M | $2.02B |
| 2024-12-31 | $272.00M | $1.59B |
| 2023-12-31 | $334.00M | $1.80B |
| 2022-12-31 | $365.00M | $1.83B |
| 2021-12-31 | $339.00M | $1.91B |
| 2020-12-31 | $438.00M | $1.98B |
| 2019-12-31 | $405.00M | $1.43B |
| 2018-12-31 | $309.60M | $1.56B |
| 2017-12-31 | $320.60M | $1.61B |
| 2016-12-31 | $383.90M | $1.51B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $104.00M | $33.00M |
| 2024-12-31 | $281.00M | $39.00M |
| 2023-12-31 | $228.00M | $46.00M |
| 2022-12-31 | $368.00M | $59.00M |
| 2021-12-31 | $515.00M | $48.00M |
| 2020-12-31 | $562.00M | $47.00M |
| 2019-12-31 | $516.00M | $66.00M |
| 2018-12-31 | $317.00M | $21.00M |
| 2017-12-31 | $457.60M | $48.00M |
| 2016-12-31 | $438.40M | $41.30M |
Dividend history
- Most recent payment
- 2025-12-26
- Paid in the last twelve months
- $0.32
| Payment date | Dividend per share |
|---|
| 2025-12-26 | $0.16 |
| 2025-09-26 | $0.16 |
| 2025-06-27 | $0.16 |
| 2025-03-28 | $0.16 |
| 2024-12-27 | $0.16 |
| 2024-09-27 | $0.16 |
| 2024-06-28 | $0.16 |
| 2024-03-27 | $0.16 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-05
- Consensus EPS estimate
- $0.30
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-06 | Jun/2026 | $0.36 |
| 2026-05-05 | - | - |
| 2026-02-26 | - | - |
| 2025-11-06 | - | - |
| 2025-08-07 | - | - |
| 2025-05-08 | - | - |
| 2025-02-27 | - | - |
| 2024-11-07 | - | - |
Filings and sources
- Company website
- dentsplysirona.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Intuitive Surgical Inc (ISRG) · Becton Dickinson & Co (BDX) · ResMed Inc (RMD) · West Pharmaceutical Services Inc (WST) · Baxter International Inc (BAX) · Align Technology Inc (ALGN) · Cooper Companies, Inc. (COO) · Vertex Pharmaceuticals Inc (VRTX)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades